Rev Med Brux. 2006 May-Jun;27(3):152-61.
The present guidelines on the management of unresectable non-metastatic non-small cell lung cancer (NSCLC) were formulated by the ELCWP in October 2005. They are designed to answer the following eight questions: 1) Is chest irradiation curative for NSCLC? 2) What are the contraindications (anatomical or functional) to chest irradiation? 3) Does the addition of chemotherapy add any advantage to radiotherapy? 4) Does the addition of radiotherapy add any advantage to chemotherapy? 5) In marginally respectable stage III is irradiation as effective as surgery? 6) How to best combine chemotherapy with radiotherapy: sequentially, concomitantly, as consolidation, as induction, as radiosensitiser? 7) In case of too advanced locoregional disease, is there a role for consolidation (salvage) local treatment (surgery, radiotherapy) after induction chemotherapy? 8) In 2005, what are the technical characteristics of an adequate radiotherapy?
欧洲肺癌工作组(ELCWP)于2005年10月制定了目前关于不可切除的非转移性非小细胞肺癌(NSCLC)的管理指南。这些指南旨在回答以下八个问题:1)胸部放疗对NSCLC有治愈作用吗?2)胸部放疗的禁忌症(解剖学或功能性)有哪些?3)化疗联合放疗是否比单纯放疗有优势?4)放疗联合化疗是否比单纯化疗有优势?5)在边缘可切除的III期患者中,放疗与手术的效果一样吗?6)如何最佳地将化疗与放疗联合:序贯、同步、巩固、诱导、作为放射增敏剂?7)如果局部区域疾病过于晚期,诱导化疗后巩固(挽救)局部治疗(手术、放疗)是否有作用?8)在2005年,充分放疗的技术特点是什么?